Academic Journal
Synthesizing the biochemical and semiconductor worlds: the future of nucleic acid nanotechnology.
| Τίτλος: | Synthesizing the biochemical and semiconductor worlds: the future of nucleic acid nanotechnology. |
|---|---|
| Συγγραφείς: | Majikes JM; Physical Measurement Laboratory, National Institute Standards and Technology, 100 Bureau drive, Gaithersburg, MD, 20878, USA. Liddle@nist.gov., Liddle JA; Physical Measurement Laboratory, National Institute Standards and Technology, 100 Bureau drive, Gaithersburg, MD, 20878, USA. Liddle@nist.gov. |
| Πηγή: | Nanoscale [Nanoscale] 2022 Nov 03; Vol. 14 (42), pp. 15586-15595. Date of Electronic Publication: 2022 Nov 03. |
| Τύπος έκδοσης: | Journal Article; Review |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: RSC Pub Country of Publication: England NLM ID: 101525249 Publication Model: Electronic Cited Medium: Internet ISSN: 2040-3372 (Electronic) Linking ISSN: 20403364 NLM ISO Abbreviation: Nanoscale Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Cambridge, UK : RSC Pub. |
| Ιατρικοί όροι (MeSH): | Nucleic Acids*, Nanotechnology ; Semiconductors |
| Περίληψη: | Since its inception nearly 40 years ago [Kallenbach, et al., Nature, 1983, 305, 829; N. C. Seeman, J. Theoretical Biology, 1982, 99, 237], Nucleic Acid Nanotechnology (NAN) has matured and is beginning to find commercial applications. For the last 20 years, it has been suggested that NAN might be an effective replacement for parts of the semiconductor lithography or protein engineering workflows. However, in that time, these incumbent technologies have made significant advances, and our understanding of NAN's strengths and weaknesses has progressed, suggesting that the greatest opportunities in fact lie elsewhere. Given the commitment of resources necessary to bring new technologies to the market and the desire to use those resources as wisely as possible, we conduct a critical examination of where NAN may benefit from, and provide benefit to, adjacent technologies and compete least with market incumbents. While the accuracy of our conclusions may be limited by our ability to extrapolate from the current state of NAN to its future commercial success, we conclude that the next promising direction is to create a bridge between biology and semiconductor technology. We also hope to stimulate a robust conversation around this technology's capabilities with the goal of building consensus on those research and development efforts that would advance NAN to the greatest effect in real-world applications. |
| References: | Angew Chem Int Ed Engl. 2017 Oct 23;56(44):13574-13589. (PMID: 28691387) Chem Rev. 2019 May 22;119(10):6384-6458. (PMID: 30714731) Adv Mater. 2019 Jun;31(26):e1806294. (PMID: 30767279) Nat Methods. 2019 Jan;16(1):95-102. (PMID: 30532082) Science. 2017 Nov 3;358(6363):633-636. (PMID: 29097546) Nano Lett. 2015 Jul 8;15(7):4672-6. (PMID: 26028443) Science. 2012 Feb 17;335(6070):831-4. (PMID: 22344439) Nat Commun. 2021 Apr 22;12(1):2371. (PMID: 33888693) Angew Chem Int Ed Engl. 2018 Mar 1;57(10):2586-2591. (PMID: 29341462) J Control Release. 2019 Dec 10;315:166-185. (PMID: 31669209) Annu Rev Biomed Eng. 2018 Jun 4;20:375-401. (PMID: 29618223) Pharmaceutics. 2020 Jul 08;12(7):. (PMID: 32650506) Chem Rev. 2019 May 22;119(10):6326-6369. (PMID: 30714375) Nat Commun. 2021 Mar 1;12(1):1358. (PMID: 33649304) Cold Spring Harb Perspect Biol. 2012 Aug 01;4(8):a005975. (PMID: 22855721) Science. 2005 Dec 9;310(5754):1661-5. (PMID: 16339440) Cell. 2018 Mar 8;172(6):1271-1293. (PMID: 29522747) Nat Nanotechnol. 2021 Jan;16(1):96-103. (PMID: 33139937) Nature. 2017 Dec 6;552(7683):72-77. (PMID: 29219968) Nano Lett. 2014 Oct 8;14(10):5740-7. (PMID: 25179827) Chem Rev. 2017 Oct 25;117(20):12584-12640. (PMID: 28605177) Molecules. 2016 Feb 06;21(2):. (PMID: 26861277) Adv Mater. 2019 May;31(21):e1808262. (PMID: 30972819) Angew Chem Int Ed Engl. 2017 Nov 13;56(46):14423-14427. (PMID: 28873273) Nat Commun. 2018 Apr 23;9(1):1600. (PMID: 29686288) Anal Chem. 2017 Mar 7;89(5):2646-2663. (PMID: 28207239) Nature. 2022 Jul;607(7919):492-498. (PMID: 35859200) Chem Sci. 2012 Aug 1;3(8):2587-2597. (PMID: 24653832) Chem Rev. 2021 Nov 24;121(22):13797-13868. (PMID: 34157230) Nat Nanotechnol. 2021 Jun;16(6):630-643. (PMID: 34059811) ACS Cent Sci. 2020 Mar 25;6(3):347-358. (PMID: 32232135) Nat Catal. 2020 Mar;3(3):295-306. (PMID: 32190819) Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18489-18496. (PMID: 32675237) Nanoscale. 2015 Apr 14;7(14):5913-21. (PMID: 25655237) ACS Nano. 2019 Jun 25;13(6):6256-6268. (PMID: 31117381) Nat Struct Biol. 1998 Oct;5(10):898-902. (PMID: 9783750) Nature. 2016 Jul 21;535(7612):401-5. (PMID: 27398616) Nat Protoc. 2017 Jun;12(6):1198-1228. (PMID: 28518172) Chembiochem. 2017 Oct 5;18(19):1873-1885. (PMID: 28714559) Angew Chem Int Ed Engl. 2020 Jul 27;59(31):12698-12702. (PMID: 32297692) Nature. 2006 Mar 16;440(7082):297-302. (PMID: 16541064) Science. 2011 Jun 3;332(6034):1196-201. (PMID: 21636773) Science. 2011 May 13;332(6031):805-9. (PMID: 21566184) J Am Chem Soc. 2012 Mar 28;134(12):5516-9. (PMID: 22414276) Nanotechnology. 2014 Aug 29;25(34):342001. (PMID: 25091409) J Am Chem Soc. 2012 Jan 25;134(3):1376-91. (PMID: 22229439) ACS Nano. 2018 Dec 26;12(12):11756-11784. (PMID: 30516055) ACS Nano. 2015 Jul 28;9(7):7133-41. (PMID: 26149412) Nat Commun. 2021 Jan 13;12(1):358. (PMID: 33441565) Nature. 2000 Apr 13;404(6779):770-4. (PMID: 10783891) Nature. 2017 Jul 20;547(7663):345-349. (PMID: 28700573) Nucleic Acids Res. 2019 Nov 18;47(20):10489-10505. (PMID: 31287874) Science. 2014 Aug 15;345(6198):799-804. (PMID: 25124436) Nat Biotechnol. 2009 Dec;27(12):1091-4. (PMID: 20010582) Chem Soc Rev. 2012 Jan 7;41(1):19-30. (PMID: 22116531) Science. 2021 Feb 19;371(6531):. (PMID: 33602826) Bioconjug Chem. 2017 Jul 19;28(7):1821-1825. (PMID: 28616969) Nanoscale. 2020 Jan 28;12(4):2555-2568. (PMID: 31932830) Nat Rev Genet. 2020 Jan;21(1):5-26. (PMID: 31636414) Nat Protoc. 2014;9(6):1367-91. (PMID: 24833175) Nat Nanotechnol. 2015 Sep;10(9):741-7. (PMID: 26329110) Science. 2020 Feb 28;367(6481):984-986. (PMID: 32108103) J Res Natl Inst Stand Technol. 2021 Jan 08;126:126001. (PMID: 39359737) ACS Nano. 2011 May 24;5(5):3405-18. (PMID: 21604810) J Am Chem Soc. 2013 Sep 11;135(36):13238-41. (PMID: 23971651) ACS Nano. 2013 Oct 22;7(10):8658-65. (PMID: 24007359) Nat Biotechnol. 2020 Oct;38(10):1113-1115. (PMID: 33020638) Chem Rev. 2020 Jan 8;120(1):288-309. (PMID: 31509383) J Am Chem Soc. 2006 Feb 15;128(6):2067-71. (PMID: 16464109) Angew Chem Int Ed Engl. 2012 Nov 5;51(45):11271-4. (PMID: 23037637) Nature. 2010 Mar 11;464(7286):158-9. (PMID: 20220817) ACS Nano. 2021 Feb 23;15(2):3284-3294. (PMID: 33565312) |
| Grant Information: | 9999-NIST United States ImNIST Intramural NIST DOC |
| Substance Nomenclature: | 0 (Nucleic Acids) |
| Entry Date(s): | Date Created: 20221021 Date Completed: 20221104 Latest Revision: 20250530 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC10949957 |
| DOI: | 10.1039/d2nr04040a |
| PMID: | 36268635 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 2040-3372 |
|---|---|
| DOI: | 10.1039/d2nr04040a |